KCC Precedent Search Options

KCC's Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results.

For information about the data provided, please review the Disclaimer statement.

Disclaimer


Notice of Effective Date:
Please take notice that the Effective Date of the Modified Joint Chapter 11 Plan of Akorn, Inc. and Its Debtor Affiliates occurred on October 1, 2020.
Attention:
Please take notice, the Confirmation Hearing was held and an Order Confirming the Modified Joint Chapter 11 Plan Akorn, Inc. and its Debtor Affiliates [Docket No. 673] was entered on September 4, 2020.
General Information:

On May 20, 2020, each of the 17 Debtors filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”). The cases are jointly administered under Case No. 20-11177 (the "Lead Case") before the Honorable Karen B. Owens in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).

For additional information, please call (877) 725-7539 (U.S./Canada) or (424) 236-7247 (International) or click here to submit an email inquiry.

Important Dates, Deadlines & Documents Show All Dates

April 3, 2024
(10:30 a.m. ET)

March 21, 2024
(1:00 p.m. ET)

October 1, 2020

November 16, 2020
(5:00 p.m. ET)

August 3, 2020
(5:00 pm ET)

May 20, 2020

December 13, 2023
(10:30 a.m. ET)

June 7, 2023
(11:00 a.m. ET)

March 8, 2023
(1:00 p.m. ET)

December 8, 2022
(9:30 a.m. ET)

November 10, 2022
(10:30 a.m. ET)

September 8, 2022
(3:00 p.m. ET)

June 15, 2022
(1:00 p.m. ET)

May 19, 2022
(10:00 a.m. ET)

April 21, 2022
(11:00 a.m. ET)

March 10, 2022
(10:00 a.m. ET)

September 1, 2020
(10:00 a.m. ET)

September 1, 2020
(10:00 a.m. ET)

August 25, 2020
(12:00 p.m. ET)

August 25, 2020
(12:00 p.m. ET)

August 25, 2020
(12:00 p.m. ET)

August 10, 2020
(9:00 a.m. ET)

July 1, 2020
(2:30 p.m. ET)

June 29, 2020
(10:00 a.m. ET)

June 15, 2020
(2:30 p.m. ET)

May 22, 2020
(2:00 p.m. ET)

(1) Meeting held and continued to July 15, 2020 at 11:00 a.m. ET

Parties & Addresses


United States Bankruptcy Court
District of Delaware
824 North Market Street, 3rd Floor
Wilmington, DE 19801
T: (302) 252-2900
http://www.deb.uscourts.gov


Akorn Claims Processing Center
c/o KCC
222 N. Pacific Coast Highway, Suite 300
El Segundo, CA 90245
T: (877) 725-7539


Please file proof(s) of claim, if any, via US Mail or other hand delivery system. Additionally, you may submit an electronic proof(s) of claim (ePOC) via this website. Facsimile and other electronic delivery methods are not acceptable. You must file an originally executed proof of claim. If you would like a copy of your claim returned to you as proof of receipt, please enclose an additional copy and a self-addressed postage-paid envelope.

Attorneys' Addresses

Patrick J. Nash, Jr., P.C.
Gregory F. Pesce
Christopher M. Hayes
Kirkland & Ellis LLP
Kirkland & Ellis International LLP
300 North LaSalle Street
Chicago, IL 60654
T: (312) 862-2000
F: (312) 862-2200
https://www.kirkland.com


Nicole L. Greenblatt, P.C.
Kirkland & Ellis LLP
Kirkland & Ellis International LLP
601 Lexington Avenue
New York, NY 10022
T: (212) 446-4800
F: (212) 446-4900
https://www.kirkland.com


Paul N. Heath
Amanda R. Steele
Zachary I. Shapiro
Brett M. Haywood
Richards, Layton & Finger, P.A.
One Rodney Square
920 North King Street
Wilmington, DE 19801
T: (302) 651-7700
F: (302) 651-7701
http://www.rlf.com


Debtors

Debtor Name
Debtor Case Number
Akorn Sales, Inc.
20-11174
Akorn, Inc.
20-11177
10 Edison Street LLC
20-11178
13 Edison Street LLC
20-11180
Advanced Vision Research, Inc.
20-11182
Akorn (New Jersey), Inc.
20-11183
Akorn Animal Health, Inc.
20-11185
Akorn Ophthalmics, Inc.
20-11186
Clover Pharmaceuticals Corp.
20-11187
Covenant Pharma, Inc.
20-11188
Hi-Tech Pharmacal Co., Inc.
20-11189
Inspire Pharmaceuticals, Inc.
20-11190
Olta Pharmaceuticals Corp.
20-11191
Oak Pharmaceuticals, Inc.
20-11192
VPI Holdings Corp.
20-11193
VersaPharm Incorporated
20-11194
VPI Holdings Sub, LLC
20-11195